- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Sep 27, 2023
Discovery & Translation
Targeting ACSS2 in solid tumors; plus a multi-lab preclinical trial and more
BioCentury’s roundup of translational innovation
BioCentury | Mar 12, 2015
Distillery Therapeutics
Therapeutics: Acyl-CoA synthetase short-chain family member 2 (ACSS2)
BioCentury | Feb 5, 2015
Distillery Therapeutics
Therapeutics: Acyl-CoA synthetase short-chain family member 2 (ACSS2)
Items per page:
1 - 6 of 6